

PRiME Seminars in AI and Drug Discovery
βπ PRiME Seminars in AI and Drug Discovery
β
βπ Unlocking the Future of Therapeutics
βJoin us for the next session in our newly launched seminar series exploring how artificial intelligence is transforming drug discovery. From molecular design to clinical prediction, each session brings leading researchers, innovators, and industry experts to share cutting edge insights.
β
βπ When
βWednesday, September 16, 2026
β3-4 pm
β
βπ Where
βLeslie Dan Faculty of Pharmacy
βRoom 850, 8th floor
β144 College St.
βUniversity of Toronto
β
βπ€ Upcoming Speaker
βDr. Joseph Brown
βAssistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
βFaculty Advisor, Medicinal Chemistry Self-Driving Lab, Acceleration Consortium
β
β"Discovery and design methods for noncanonical peptides"
β
βJoseph S. Brown is an Assistant Professor at the Leslie Dan Faculty of Pharmacy (Jan 2026) and Faculty Advisor to the Medicinal Chemistry Self-Driving Lab (MedChem SDL) at the University of Toronto. His research combines automated chemistry, bioassays, and machine learning for peptide and peptidomimetic drug discovery. Before his faculty appointment, Joseph was a Staff Scientist with the MedChem SDL, helping build automated assays and models for the navigation of chemical space for the discovery and optimization of therapeutic candidates. He was previously a PhRMA Foundation Drug Discovery Postdoctoral Fellow at the Massachusetts Institute of Technology with Bradley Pentelute. Though he led projects in phage display, medicinal chemistry, and automated chemical synthesis of proteins, Joseph specialized in combining machine learning (deep and unsupervised) with affinity selection-mass spectrometry (AS-MS) to identify high-affinity ligands from diverse peptide and abiotic libraries. Last, Joseph earned his PhD in Chemical and Biomolecular Engineering from Cornell University with Chris Alabi as a National Science Foundation Graduate Research Fellow. His doctoral work combined organic chemistry and biological characterization to design and evaluate antimicrobial peptidomimetics, establishing mechanistic and structure-activity relationships that continue to inform his approach to molecular design.
β
βπ Registration & Details
βEveryone is welcome to attend.
βGraduate students interested in having their attendance at these seminars on their transcript can sign up for the seminar course PHM3100 (0.13 FCE: CR/NCR). All students are welcome to join, but since the deadline for registration has passed, request access to the course using the Course Add/Drop form that you submit to your grad program coordinator.
βHybrid available on demand. Link will be provided upon request, please contact prime.initiative@utoronto.ca.
β
βFor more information, please contact organizer:
βCarolyn Cummins, PhD
βAssociate Professor, Pharmaceutical Sciences